Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)

ClinicalTrials.gov ID: NCT04295538

Public ClinicalTrials.gov record NCT04295538. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Traumatic Cervical Spinal Cord Injury

Study identification

NCT ID
NCT04295538
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

  • Elezanumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 5, 2020
Primary completion
Jan 25, 2026
Completion
Jan 25, 2026
Last update posted
Feb 10, 2026

2020 – 2026

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
University of California Davis Health /ID# 224892 Sacramento California 95817
Shepherd Center, Inc /ID# 230370 Atlanta Georgia 30309-1426
Northwestern University Feinberg School of Medicine /ID# 218009 Chicago Illinois 60611-2927
University of Louisville Hospital /ID# 215948 Louisville Kentucky 40202
Duplicate_Tufts Medical Center /ID# 225410 Boston Massachusetts 02111
Brigham & Women's Hospital /ID# 216342 Boston Massachusetts 02115
Duplicate_Boston University School of Medicine /ID# 218371 Boston Massachusetts 02118-2515
Beth Israel Deaconess Medical Center /ID# 218149 Boston Massachusetts 02215-5400
Regents of the University of Michigan /ID# 215890 Ann Arbor Michigan 48109-1276
Washington University-School of Medicine /ID# 215325 St Louis Missouri 63110
Hackensack Univ Med Ctr /ID# 215754 Hackensack New Jersey 07601
Jersey Shore University Medical Center /ID# 218162 Neptune City New Jersey 07753-4859
Rutgers New Jersey School of Medicine /ID# 216212 Newark New Jersey 07103
Duplicate_Duke Cancer Center /ID# 216888 Durham North Carolina 27710-3000
Oregon Medical Research Center /ID# 227371 Portland Oregon 97239
University of Pennsylvania /ID# 218662 Philadelphia Pennsylvania 19104-5502
Thomas Jefferson University Hospital /ID# 215460 Philadelphia Pennsylvania 19107
University of Virginia Health /ID# 218117 Charlottesville Virginia 22908
Sentara Norfolk General Hospital /ID# 218302 Norfolk Virginia 23507
Virginia Commonwealth University Medical Center Main Hospital /ID# 217481 Richmond Virginia 23219
West Virginia University Hospitals /ID# 217344 Morgantown West Virginia 26506
Wisconsin Medical Center /ID# 215610 Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04295538, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04295538 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →